牛支原体的分离鉴定及中药体外抗菌作用OA
Isolation and Identification of Mycoplasma bovis and Antibacterial Effect of Traditional Chinese Medicine In Vitro
为了解我国不同地区牛支原体分布及耐药情况,并初步筛选对牛支原体有效的中药.本试验于2023年11月在安徽、内蒙古、云南等7个地区的不同牧场采集84份病料,包括疑似感染牛支原体而患有呼吸道疾病的牛只鼻拭子和病死牛只的肺脏病料,进行病原分离培养,通过菌落和菌体形态观察、特异性基因oppD/F、uvrC扩增及16S rRNA基因序列分析对分离株进行鉴定;进行体外药物敏感性试验,测定8种抗菌药物和10种中药水煎液对分离株的体外抗菌作用.结果显示,84份病料中共鉴定出27份呈牛支原体阳性,分离得到4株牛支原体,命名为Mb1~Mb4.分离株在支原体(PPLO)固体培养基上呈针尖大小的白色菌落,Dienes染色后菌落呈蓝色,扫描电镜下分离株呈球形;特异性基因oppD/F、uvrC和16S rRNA基因扩增结果均与牛支原体预期目的条带一致,16S rRNA基因序列与NCBI中牛支原体序列相似性均达99.7%以上.体外药物敏感性试验结果显示,4株分离株均为多重耐药菌,且对7种抗菌药物均存在不同程度的耐药;黄连、五味子、丁香和黄芩水煎液对4株分离株的体外抗菌效果较好,最小抑菌浓度(MIC)值分别为7.81、15.63、31.25和62.50 mg/mL.结果表明,牛支原体在多地规模化牛场均有流行且分离株耐药严重,黄连、五味子、丁香、黄芩对其有良好抗菌潜力,可作为抗牛支原体中药进一步研究.本试验探究了我国多地牛支原体分布及耐药情况,证实了中药对牛支原体的抗菌潜力,为研发相关中药复方和新型制剂提供理论参考.
To investigate the distribution and antimicrobial resistance of Mycoplasma bovis in different regions of China and to preliminarily screen effective traditional Chinese medicines against Mycoplasma bovis,a total of 84 samples were collected in November 2023 from cattle suspected of Mycoplasma bovis infection with respiratory diseases(nasal swabs)and lung tissues from dead cattle across seven regions,including Anhui,Inner Mongolia,and Yunnan.Pathogen isolation and culture were conducted,and the isolates were identified based on colony and cell morphology,specific gene(oppD/F,uvrC)amplification,and 16S rRNA gene sequence analysis.In vitro antimicrobial susceptibility tests were performed to evaluate the effects of eight antibiotics and ten traditional Chinese medicines water decoctions against the isolates.The results showed that 27 of the 84 samples were Mycoplasma bovis positive,and four isolates,designated Mb1-Mb4,were obtained.On pleuropneumonia like organism broth(PPLO)solid medium,the isolates formed pinhead-sized white colonies that appeared blue after Dienes staining;scanning electron microscopy revealed spherical cells.PCR amplification of oppD/F,uvrC,and 16S rRNA genes yielded the expected bands specific to Mycoplasma bovis,and 16S rRNA sequences showed>99.7%similarity with reference Mycoplasma bovis sequences in NCBI.Antimicrobial susceptibility tests demonstrated that all four isolates were multidrug-resistant,showing varying degrees of resistance to seven antibiotics.Among the tested traditional Chinese medicines,Coptis chinensis(Huanglian),Schisandra chinensis(Wuweizi),Syzygium aromaticum(Clove),and Scutellaria baicalensis(Huangqin)exhibited strong antibacterial activity against all isolates,with minimum inhibitory concentration(MIC)values of 7.81,15.63,31.25,and 62.50 mg/mL,respectively.These results indicate that Mycoplasma bovis is prevalent in large-scale cattle farms across multiple regions of China,with isolates showing severe antimicrobial resistance.Coptis chinensis,Schisandra chinensis,Syzygium aromaticum,and Scutellaria baicalensis demonstrated good antibacterial potential against Mycoplasma bovis and may serve as promising traditional Chinese medicinal candidates for further investigation.This study investigated the distribution and antimicrobial resistance of Mycoplasma bovis in multiple regions of China and confirmed the antibacterial potential of traditional Chinese medicines against this pathogen,providing a theoretical basis for the development of related Chinese herbal compound formulations and novel preparations.
刘日蓉;夏东旭;韩凯凡;施伟;刘淑英;樊宏亮;赵红霞;苏建国
内蒙古农业大学兽医学院,内蒙古 呼和浩特 010010内蒙古农业大学兽医学院,内蒙古 呼和浩特 010010内蒙古农业大学兽医学院,内蒙古 呼和浩特 010010内蒙古农业大学兽医学院,内蒙古 呼和浩特 010010内蒙古农业大学兽医学院,内蒙古 呼和浩特 010010内蒙古优然牧业有限责任公司,内蒙古 呼和浩特 010070内蒙古农业大学兽医学院,内蒙古 呼和浩特 010010鄂尔多斯生态环境职业学院生物技术系,内蒙古 鄂尔多斯 017010
农业科技
牛支原体分离鉴定中药
Mycoplasma bovisisolationidentificationtraditional Chinese medicine
《中国兽医杂志》 2026 (4)
111-119,9
内蒙古自治区科技重大专项项目(2021ZD0013)
评论